Assessment of the association of ESBL-producing Escherichia coli with clinical severity of chronic enteropathy in dogs in Brazil

Abstract

Canine chronic enteropathy (CCE) includes persistent gastrointestinal disorders that may be associated with antimicrobial-resistant bacteria. We evaluated the correlation between clinical severity of CCE and the presence of extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli in dogs with CCE. We assessed 64 dogs using the canine chronic enteropathy clinical activity index (CCECAI) and analyzed rectal swabs for E. coli and ESBL detection. E. coli was isolated from 28 dogs (44%), with ESBL-positive strains identified in 8 (12%). All ESBL-positive cases had severe clinical scores (CCECAI ≥ 9), with a strong association between ESBL phenotype and disease severity (p < 0.001). These multidrug-resistant isolates remained susceptible to imipenem. Histologic findings confirmed marked intestinal inflammation in ESBL-positive cases. No age or sex association was observed. Our results emphasize the clinical relevance of ESBL-producing E. coli in severe CCE and support the inclusion of microbial profiling in diagnostic and therapeutic strategies.

Keywords

antimicrobial resistance canine chronic enteropathy

Get full access to this article

View all access options for this article.

References

Allenspach

, et al. Chronic enteropathies in dogs: evaluation of risk factors for negative outcome. J Vet Intern Med 2007;21:700–708.

Cassmann

, et al. Alterations of the ileal and colonic mucosal microbiota in canine chronic enteropathies. PLoS One 2016;11:e0147321.

Clinical and Laboratory Standards Institute (CLSI). Performance Standards for Antimicrobial Disk and Dilution Susceptibility Tests for Bacteria Isolated from Animals. 6th ed. CLSI, 2023. CLSI supplement VET01S.

Clinical and Laboratory Standards Institute (CLSI). Performance Standards for Antimicrobial Disk Susceptibility Tests. 13th ed. CLSI, 2018/2020. CLSI document M02.

Clinical and Laboratory Standards Institute (CLSI). Performance Standards for Antimicrobial Susceptibility Testing. 34th ed. CLSI, 2024. CLSI supplement M100.

Clinical and Laboratory Standards Institute (CLSI). Performance Standards for Antimicrobial Susceptibility Testing of Bacteria Isolated from Animals. 4th ed. CLSI, 2018. CLSI supplement VET08.

Dandrieux

JRS

. Inflammatory bowel disease versus chronic enteropathy in dogs: are they one and the same? J Small Anim Pract 2016;57:589–599.

Guardabassi

, et al. Pet animals as reservoirs of antimicrobial-resistant bacteria. J Antimicrob Chemother 2004;54:321–332.

Jergens

Heilmann

RM.

Canine chronic enteropathy—current state-of-the-art and emerging concepts. Front Vet Sci 2022;9:923013.

10.

Koneman

, et al. Color Atlas and Textbook of Diagnostic Microbiology. 5th ed. Lippincott Williams & Wilkins, 2001.

11.

Pitout

JDD

Laupland

KB.

Extended-spectrum β-lactamase-producing Enterobacteriaceae: an emerging public-health concern. Lancet Infect Dis 2008;8:159–166.

12.

Schmidt

, et al. Routine antibiotic therapy in dogs increases the detection of antimicrobial-resistant faecal Escherichia coli. J Antimicrob Chemother 2018;73:3305–3316.

13.

Suchodolski

JS.

The fecal microbiome in dogs with acute diarrhea and idiopathic inflammatory bowel disease. PLoS One 2012;7:e51907.